Peginterferon alfa-2b Interactions
There are 228 drugs known to interact with peginterferon alfa-2b, along with 20 disease interactions. Of the total drug interactions, 41 are major, 183 are moderate, and 4 are minor.
- View all 228 medications that may interact with peginterferon alfa-2b
- View peginterferon alfa-2b disease interactions (20)
Most frequently checked interactions
View interaction reports for peginterferon alfa-2b and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Acetylsalicylic Acid (aspirin)
- Adderall (amphetamine / dextroamphetamine)
- Adderall (amphetamine / dextroamphetamine)
- Aleve (naproxen)
- Aleve (naproxen)
- Ativan (lorazepam)
- Ativan (lorazepam)
- Avelox (moxifloxacin)
- Avelox (moxifloxacin)
- Avodart (dutasteride)
- Avodart (dutasteride)
- Benadryl (diphenhydramine)
- Benadryl (diphenhydramine)
- Chantix (varenicline)
- Chantix (varenicline)
- Claritin (loratadine)
- Claritin (loratadine)
- Concerta (methylphenidate)
- Concerta (methylphenidate)
- Effexor XR (venlafaxine)
- Effexor XR (venlafaxine)
- Incivek (telaprevir)
- Incivek (telaprevir)
- Nexium (esomeprazole)
- Nexium (esomeprazole)
- Symbicort (budesonide / formoterol)
- Symbicort (budesonide / formoterol)
- Zoloft (sertraline)
- Zoloft (sertraline)
Peginterferon alfa-2b disease interactions
There are 20 disease interactions with peginterferon alfa-2b which include:
- renal dysfunction
- autoimmune diseases
- cardiac disease
- CNS dysfunction
- depression
- thyroid dysfunction
- autoimmune hepatitis
- depression
- severe hepatic disease
- hemoglobinopathies
- renal dysfunction
- colitis
- diabetes mellitus
- myelosuppression
- peripheral neuropathy
- bone marrow suppression
- endocrine disorders
- ophthalmological disorders
- pancreatitis
- pulmonary disorders
Report options
More about peginterferon alfa-2b
- peginterferon alfa-2b consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic interferons
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Tecentriq
Tecentriq (atezolizumab) is a monoclonal antibody used to treat non-small cell lung cancer, small ...
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Opdualag
Opdualag (nivolumab and relatlimab-rmbw) is used for the treatment of unresectable or metastatic ...
Interferon alfa-2b
Interferon alfa-2b is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated ...
Dacarbazine
Dacarbazine is used for hodgkin's lymphoma, melanoma, melanoma, metastatic
Ipilimumab
ipilimumab (Yervoy) is an immunotherapy used for melanoma, renal cell carcinoma, non-small cell ...
Atezolizumab
Atezolizumab (Tecentriq) is a type of immunotherapy drug that helps the body's immune system to ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.